Steven Robert Alberts, MD

  • 14903 Citations
  • 52 Scopus h-Index
1976 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1987 2019

  • 14903 Citations
  • 52 Scopus h-Index
  • 200 Article
  • 3 Chapter
  • 3 Review article
  • 2 Letter
1987
6 Citations (Scopus)

Leukemia, lymphoma, and multiple myeloma in Alaskan natives

Alberts, S. R. & Lanier, A. P., 1987, In : Journal of the National Cancer Institute. 78, 5, p. 831-837 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Population Groups
Lymphoma
Leukemia
Mycosis Fungoides
23 Citations (Scopus)

Primary liver cancer in Alaskan natives: 1980-1985

Lanier, A. P., McMahon, B. J., Alberts, S. R., Popper, H. & Heyward, W. L., 1987, In : Cancer. 60, 8, p. 1915-1920 6 p.

Research output: Contribution to journalArticle

Liver Neoplasms
Population Groups
Hepatocellular Carcinoma
Hepatitis B Surface Antigens
Acinar Cell Carcinoma
1988
21 Citations (Scopus)

Evolution of hepatocellular carcinoma associated with chronic hepatitis B virus infection in Alaskan Eskimos

Popper, H., Thung, S. N., McMahon, B. J., Lanier, A. P., Hawkins, I. & Alberts, S. R., 1988, In : Archives of Pathology and Laboratory Medicine. 112, 5, p. 498-504 7 p.

Research output: Contribution to journalArticle

Inuits
Chronic Hepatitis B
Virus Diseases
Hepatitis B virus
Hepatocellular Carcinoma
1990
249 Citations (Scopus)

Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers

McMahon, B. J., Alberts, S. R., Wainwright, R. B., Bulkow, L. & Lanier, A. P., 1990, In : Archives of Internal Medicine. 150, 5, p. 1051-1054 4 p.

Research output: Contribution to journalArticle

Hepatitis B Surface Antigens
Hepatitis B
Hepatocellular Carcinoma
Prospective Studies
Chronic Hepatitis
1991
27 Citations (Scopus)

Clustering of hepatocellular carcinoma in Alaska Native families

Alberts, S. R., Lanier, A. P., McMahon, B. J., Harpster, A., Bulkow, L. R., Heyward, W. L. & Murray, C., 1991, In : Genetic Epidemiology. 8, 2, p. 127-139 13 p.

Research output: Contribution to journalArticle

Cluster Analysis
Hepatocellular Carcinoma
Hepatitis B virus
Lymphocytes
Antigens
1994
185 Citations (Scopus)

p53 Mutations and microsatellite instability in sporadic gastric cancer: When guardians fail

Strickler, J. G., Zheng, J., Alberts, S. R., Burgart, L. J., Alberts, S. R. & Shibata, D., Sep 1 1994, In : Cancer Research. 54, 17, p. 4750-4755 6 p.

Research output: Contribution to journalArticle

Microsatellite Instability
Stomach Neoplasms
Mutation
Neoplasms
Stomach
1996

Adjuvant therapy for colon cancer: A review of current approaches and future directions

Alberts, S. R. & Erlichman, C., 1996, In : Seminars in Colon and Rectal Surgery. 7, 1, p. 40-46 7 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
Levamisole
Adjuvant Chemotherapy
Group Psychotherapy
Fluorouracil
20 Citations (Scopus)

Cancers of the buccal cavity and pharynx in Circumpolar Inuit

Lanier, A. P. & Alberts, S. R., 1996, In : Acta Oncologica. 35, 5, p. 545-552 8 p.

Research output: Contribution to journalArticle

Tongue Neoplasms
Cheek
Mouth Neoplasms
Pharynx
Lip Neoplasms
61 Citations (Scopus)

Comparison of estrogen receptor determinations by a biochemical ligand- binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials

Alberts, S. R., Ingle, J. N., Roche, P. R., Cha, S. S., Wold, L. E., Farr, G. H., Krook, J. E. & Wieand, H. S., Aug 15 1996, In : Cancer. 78, 4, p. 764-772 9 p.

Research output: Contribution to journalArticle

Charcoal
Estrogen Receptors
Dextrans
Lymph Nodes
Monoclonal Antibodies
9 Citations (Scopus)

Kidney and bladder cancer in Inuit 1969-1988

Lanier, A. P. & Alberts, S. R., 1996, In : Acta Oncologica. 35, 5, p. 595-599 5 p.

Research output: Contribution to journalArticle

Kidney Neoplasms
Urinary Bladder Neoplasms
Lung Neoplasms
Inuits
Greenland
3 Citations (Scopus)

Malignant neoplasms of the lymphatic and haematopoietic system in Circumpolar Inuit

Lanier, A. P. & Alberts, S. R., 1996, In : Acta Oncologica. 35, 5, p. 601-606 6 p.

Research output: Contribution to journalArticle

Hematopoietic System
Lymphatic System
Leukemia
Neoplasms
Hodgkin Disease
1997
1 Citation (Scopus)
Dioxins
Environmental Exposure
Multiple Myeloma
Incidence
Neoplasms
1998
22 Citations (Scopus)

Phase I study of the duocarmycin semisynthetic derivative KW-2189 given daily for five days every six weeks

Alberts, S. R., Erlichman, C., Reid, J. M., Sloan, J. A., Ames, M. M., Richardson, R. L. & Goldberg, R. M., Sep 1998, In : Clinical Cancer Research. 4, 9, p. 2111-2117 7 p.

Research output: Contribution to journalArticle

Drug Therapy
Maximum Tolerated Dose
Leukopenia
Streptomyces
Neutropenia
1999
21 Citations (Scopus)

Idiopathic thrombocytopenic purpura associated with breast cancer: A case report and review of the current literature

Porrata, L. F., Alberts, S. R., Hook, C. & Hanson, C. A., Aug 1999, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 22, 4, p. 411-413 3 p.

Research output: Contribution to journalArticle

Idiopathic Thrombocytopenic Purpura
Thrombocytopenia
Breast Neoplasms
Megakaryocytes
Blood Platelets
71 Citations (Scopus)

Incremental costs of enrolling cancer patients in clinical trials: A population-based study

Wagner, J. L., Alberts, S. R., Sloan, J. A., Cha, S., Killian, J., O'Cornell, M. J., Van Grevenhof, P., Lindman, J. & Chute, C. G., May 19 1999, In : Journal of the National Cancer Institute. 91, 10, p. 847-853 7 p.

Research output: Contribution to journalArticle

Clinical Trials
Costs and Cost Analysis
Population
Neoplasms
Hospital Ancillary Services
32 Citations (Scopus)

Therapy for early-stage colorectal cancer

Peeters, M., Haller, D. G., Alberts, S. R., Goldberg, R. M. & Smith, R., 1999, In : Oncology. 13, 3, p. 307-321 15 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Radiotherapy
Leucovorin
Fluorouracil
Colonic Neoplasms
31 Citations (Scopus)
Asparaginase
Blood Coagulation Factors
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Thrombosis
Central Nervous System
2000
12 Citations (Scopus)

History of the development of antiemetic guidelines at Mayo Clinic Rochester

Loprinzi, C. L., Alberts, S. R., Christensen, B. J., Hanson, L. J., Farley, D. R., Broers, J. K., Betcher, D. L., Grady, R. E., Southorn, P. A., Johnson, T. M. & Perez, E. A., 2000, In : Mayo Clinic Proceedings. 75, 3, p. 303-309 7 p.

Research output: Contribution to journalArticle

Antiemetics
Guidelines
Costs and Cost Analysis
Drug Therapy
Quality of Health Care
1 Citation (Scopus)

Intrahepatic therapy for resected hepatic metastases from colorectal carcinoma

Alberts, S. R., 2000, In : Oncology. 14, 12 SUPPL. 11, p. 48-51 4 p.

Research output: Contribution to journalArticle

oxaliplatin
Colorectal Neoplasms
Fluorouracil
Neoplasm Metastasis
Liver
14 Citations (Scopus)

New adjuvant therapy for colon cancer: Justified hope or commercial hype

Galanis, E., Alberts, S. R. & O'Connell, M. J., 2000, In : Surgical Oncology Clinics of North America. 9, 4, p. 813-823 11 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
oxaliplatin
irinotecan
Adjuvant Chemotherapy
Pyrimidines
53 Citations (Scopus)

Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: Preliminary evidence of clinical activity

Adjei, A., Klein, C. E., Kastrissios, H., Goldberg, R. M., Alberts, S. R., Pitot, H. C., Sloan, J. A., Reid, J. M., Hanson, L. J., Atherton, P., Rubin, J. & Erlichman, C., Mar 2000, In : Journal of Clinical Oncology. 18, 5, p. 1116-1123 8 p.

Research output: Contribution to journalArticle

irinotecan
docetaxel
Pharmacokinetics
Neoplasms
National Cancer Institute (U.S.)
116 Citations (Scopus)

Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumors

Adjei, A., Erlichman, C., Sloan, J. A., Reid, J. M., Pitot, H. C., Goldberg, R. M., Peethambaram, P., Atherton, P., Hanson, L. J., Alberts, S. R. & Jett, J., Apr 2000, In : Journal of Clinical Oncology. 18, 8, p. 1748-1757 10 p.

Research output: Contribution to journalArticle

gemcitabine
Folic Acid Antagonists
Proxy
Neoplasms
Neutropenia
71 Citations (Scopus)

Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy

Pitot, H. C., Goldberg, R. M., Reid, J. M., Sloan, J. A., Skaff, P. A., Erlichman, C., Rubin, J., Burch, P. A., Adjei, A., Alberts, S. R., Schaaf, L. J., Elfring, G. & Miller, L. L., Jun 2000, In : Clinical Cancer Research. 6, 6, p. 2236-2244 9 p.

Research output: Contribution to journalArticle

irinotecan
Appointments and Schedules
Pharmacokinetics
Neoplasms
Maximum Tolerated Dose
2001
17 Citations (Scopus)

Chemoprevention for prostatic carcinoma: The role of flutamide in patients with prostatic intraepithelial neoplasia

Alberts, S. R. & Blute, M. L., 2001, In : Urology. 57, 4 SUPPL. 1, p. 188-190 3 p.

Research output: Contribution to journalArticle

Prostatic Intraepithelial Neoplasia
Flutamide
Chemoprevention
Carcinoma
Adenocarcinoma
7 Citations (Scopus)

Pancreatic cancer in the older patient

Jacobson, S. D., Alberts, S. R. & O'Connell, M. J., 2001, In : Oncology. 15, 7, p. 926-932 7 p.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Clinical Trials
Radiation
Drug Therapy
Therapeutics
67 Citations (Scopus)

Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566

Erlichman, C., Adjei, A., Alberts, S. R., Sloan, J. A., Goldberg, R. M., Pitot, H. C., Rubin, J., Atherton, P. J., Klee, G. G. & Humphrey, R., 2001, In : Annals of Oncology. 12, 3, p. 389-395 7 p.

Research output: Contribution to journalArticle

Matrix Metalloproteinase Inhibitors
Matrix Metalloproteinase 3
Matrix Metalloproteinase 2
Matrix Metalloproteinase 9
Fibroblast Growth Factor 2
7 Citations (Scopus)

Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks

Alberts, S. R., Erlichman, C., Sloan, J. A., Okuno, S. H., Burch, P. A., Rubin, J., Pitot, H. C., Goldherg, R. M., Adjei, A., Atherton, P. J. & Kaufmann, S. H., 2001, In : Annals of Oncology. 12, 5, p. 627-631 5 p.

Research output: Contribution to journalArticle

irinotecan
gemcitabine
Maximum Tolerated Dose
Transitional Cell Carcinoma
Alopecia
2002
6 Citations (Scopus)

A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancer

Adjei, A., Reid, J. M., Erlichman, C., Sloan, J. A., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Hanson, L. J., Ruben, S., Boerner, S. A., Atherton, P., Ames, M. M. & Kaufmann, S. H., 2002, In : Investigational New Drugs. 20, 3, p. 297-304 8 p.

Research output: Contribution to journalArticle

NSC 366140
Carboplatin
Area Under Curve
Neoplasms
DNA Adducts
30 Citations (Scopus)

A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia

Jatoi, A., Tirona, M. T., Cha, S. S., Alberts, S. R., Rowland, K. M., Morton, R. F., Nair, S., Kardinal, C. G., Stella, P. J., Mailliard, J. A., Sargent, D. & Goldberg, R. M., 2002, In : International Journal of Gastrointestinal Cancer. 32, 2-3, p. 115-123 9 p.

Research output: Contribution to journalArticle

irinotecan
docetaxel
Esophagogastric Junction
Cardia
Stomach
11 Citations (Scopus)

A phase I study of sequential irinotecan and 5-fluorouracil/leucovorin

Goldberg, R. M., Kaufmann, S. H., Atherton, P., Sloan, J. A., Adjei, A., Pitot, H. C., Alberts, S. R., Rubin, J., Miller, L. L. & Erlichman, C., Oct 1 2002, In : Annals of Oncology. 13, 10, p. 1674-1680 7 p.

Research output: Contribution to journalArticle

irinotecan
Leucovorin
Fluorouracil
Colorectal Neoplasms
Appointments and Schedules
27 Citations (Scopus)

Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumors

Adjei, A., Reid, J. M., Diasio, R. B., Sloan, J. A., Smith, D. A., Rubin, J., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Hanson, L. J., Atherton, P., Ames, M. M. & Erlichman, C., Mar 15 2002, In : Journal of Clinical Oncology. 20, 6, p. 1683-1691 9 p.

Research output: Contribution to journalArticle

Fluorouracil
Pharmacokinetics
Neoplasms
Dihydrouracil Dehydrogenase (NADP)
eniluracil
30 Citations (Scopus)

CPT-11 for bile-duct and gallbladder carcinoma: A phase II North Central Cancer Treatment Group (NCCTG) study

Alberts, S. R., Fishkin, P. A., Burgart, L. J., Cera, P. J., Mahoney, M. R., Morton, R. F., Johnson, P. A., Nair, S. & Goldberg, R. M., 2002, In : International Journal of Gastrointestinal Cancer. 32, 2-3, p. 107-114 8 p.

Research output: Contribution to journalArticle

irinotecan
Bile Ducts
Gallbladder
Carcinoma
Neoplasms
25 Citations (Scopus)

Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: A North Central Cancer Treatment Group (NCCTG) phase I study

Alberts, S. R., Townley, P. M., Goldberg, R. M., Cha, S. S., Moore, D. F., Krook, J. E., Pitot, H. C., Fitch, T. R., Wiesenfeld, M., Mailliard, J. A. & Sargent, D. J., 2002, In : Annals of Oncology. 13, 4, p. 553-557 5 p.

Research output: Contribution to journalArticle

oxaliplatin
gemcitabine
Pancreatic Neoplasms
Maximum Tolerated Dose
Neoplasms
29 Citations (Scopus)

High-folate diets and breast cancer survival in a prospective cohort study

Sellers, T. A., Alberts, S. R., Vierkant, R. A., Grabrick, D. M., Cerhan, J. R., Vachon, C. M., Olson, J. E., Kushi, L. H. & Potter, J. D., 2002, In : Nutrition and Cancer. 44, 2, p. 139-144 6 p.

Research output: Contribution to journalArticle

cohort studies
Folic Acid
folic acid
breast neoplasms
Cohort Studies
23 Citations (Scopus)

Phase II trial of KW2189 in patients with advanced malignant melanoma

Markovic, S. N., Suman, V. J., Vukov, A. M., Fitch, T. R., Hillman, D. W., Adjei, A., Alberts, S. R., Kaur, J. S., Braich, T. A., Leitch, J. M. & Creagan, E. T., 2002, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 25, 3, p. 308-312 5 p.

Research output: Contribution to journalArticle

Melanoma
Neutropenia
Thrombocytopenia
Therapeutics
Tumor Cell Line
2003
14 Citations (Scopus)

A phase II study of topical ceramides for cutaneous breast cancer

Jatoi, A., Suman, V. J., Schaefer, P., Block, M., Loprinzi, C. L., Roche, P., Garneau, S., Morton, R., Stella, P. J., Alberts, S. R., Pittelkow, M., Sloan, J. A. & Pagano, R., Jul 2003, In : Breast Cancer Research and Treatment. 80, 1, p. 99-104 6 p.

Research output: Contribution to journalArticle

Ceramides
Skin Neoplasms
Breast Neoplasms
Apoptosis
Skin
74 Citations (Scopus)

A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer

Adjei, A., Dy, G. K., Erlichman, C., Reid, J. M., Sloan, J. A., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Hanson, L. J., Atherton, P. J., Watanabe, T., Geary, R. S., Holmlund, J. & Dorr, F. A., Jan 1 2003, In : Clinical Cancer Research. 9, 1 I, p. 115-123 9 p.

Research output: Contribution to journalArticle

gemcitabine
Neoplasms
Pharmacokinetics
Ideal Body Weight
National Cancer Institute (U.S.)
47 Citations (Scopus)

A phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer

Adjei, A., Croghan, G. A., Erlichman, C., Marks, R. S., Reid, J. M., Sloan, J. A., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Hanson, L. J., Bruzek, L. M., Atherton, P., Thibault, A., Palmer, P. A. & Kaufmann, S. H., Jul 1 2003, In : Clinical Cancer Research. 9, 7, p. 2520-2526 7 p.

Research output: Contribution to journalArticle

gemcitabine
tipifarnib
Transferases
Cisplatin
Maximum Tolerated Dose
307 Citations (Scopus)

Gastric cancer: Epidemiology, pathology and treatment

Alberts, S. R., Cervantes, A. & van de Velde, C. J. H., 2003, In : Annals of Oncology. 14, SUPPL. 2

Research output: Contribution to journalArticle

Stomach Neoplasms
Epidemiology
Pathology
Fluorouracil
Drug Therapy
57 Citations (Scopus)

Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: A North Central Cancer Treatment Group phase II study

Alberts, S. R., Townley, P. M., Goldberg, R. M., Cha, S. S., Sargent, D. J., Moore, D. F., Krook, J. E., Pitot, H. C., Fitch, T. R., Wiesenfeld, M. & Mailliard, J. A., Apr 2003, In : Annals of Oncology. 14, 4, p. 580-585 6 p.

Research output: Contribution to journalArticle

oxaliplatin
gemcitabine
Adenocarcinoma
Neoplasms
Therapeutics
14 Citations (Scopus)

OncoSurge: A strategy for long-term survival in metastatic colorectal cancer

Alberts, S. R. & Poston, G., Nov 2003, In : Colorectal Disease. 5, SUPPL. 3, p. 20-28 9 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
oxaliplatin
Neoplasm Metastasis
Survival
Liver
2004
1922 Citations (Scopus)

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer

Goldberg, R. M., Sargent, D. J., Morton, R. F., Fuchs, C. S., Ramanathan, R. K., Williamson, S. K., Findlay, B. P., Pitot, H. C. & Alberts, S. R., 2004, In : Journal of Clinical Oncology. 22, 1, p. 23-30 8 p.

Research output: Contribution to journalArticle

irinotecan
oxaliplatin
Leucovorin
Fluorouracil
Colorectal Neoplasms
80 Citations (Scopus)

Gemcitabine and ISIS-2503 for patients with locally advanced or metastatic pancreatic adenocarcinoma: A North Central Cancer Treatment Group phase II trial

Alberts, S. R., Schroeder, M., Erlichman, C., Steen, P. D., Foster, N. R., Moore, D. F., Rowland, K. M., Nair, S., Tschetter, L. K. & Fitch, T. R., Dec 15 2004, In : Journal of Clinical Oncology. 22, 24, p. 4944-4950 7 p.

Research output: Contribution to journalArticle

gemcitabine
Adenocarcinoma
Neoplasms
Therapeutics
Survival
151 Citations (Scopus)

Liver transplantation for unresectable perihilar cholangiocarcinoma

Heimbach, J. K., Gores, G. J., Haddock, M., Alberts, S. R., Nyberg, S., Ishitani, M. B. & Rosen, C. B., May 2004, In : Seminars in Liver Disease. 24, 2, p. 201-207 7 p.

Research output: Contribution to journalArticle

Klatskin Tumor
Liver Transplantation
Transplantation
Neoadjuvant Therapy
Survival
736 Citations (Scopus)

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: Who benefits and by how much?

Gill, S., Loprinzi, C. L., Sargent, D. J., Thome, S., Alberts, S. R., Haller, D. G., Benedetti, J., Francini, G., Shepherd, L. E., Seitz, J. F., Labianca, R., Chen, W., Cha, S. S., Heldebrant, M. P. & Goldberg, R. M., 2004, In : Journal of Clinical Oncology. 22, 10, p. 1797-1806 10 p.

Research output: Contribution to journalArticle

Fluorouracil
Colonic Neoplasms
Survival
Therapeutics
Disease-Free Survival
8 Citations (Scopus)
Amifostine
Carboplatin
Esophageal Neoplasms
Paclitaxel
Fluorouracil
73 Citations (Scopus)

Transplantation for hilar cholangiocarcinoma

Heimbach, J. K., Haddock, M., Alberts, S. R., Nyberg, S., Ishitani, M. B., Rosen, C. B. & Gores, G. J., Oct 2004, In : Liver Transplantation. 10, 10 SUPPL. 2

Research output: Contribution to journalArticle

Klatskin Tumor
Cholangiocarcinoma
Transplantation
Liver Transplantation
Sclerosing Cholangitis
5 Citations (Scopus)

Treatment endpoints for advanced cholangiocarcinoma

Gores, G. J., Baskin-Bey, E. S., Baron, T. H. & Alberts, S. R., Nov 2004, In : Nature Clinical Practice Gastroenterology and Hepatology. 1, 1, p. 4-5 2 p.

Research output: Contribution to journalArticle

Bile Duct Neoplasms
Intrahepatic Bile Ducts
Cholangiocarcinoma
Clinical Trials
2005
21 Citations (Scopus)

A phase I and pharmacokinetic study of the selective, non-peptidic inhibitor of matrix metalloproteinase BAY 12-9566 in combination with etoposide and carboplatin

Molina, J. R., Reid, J. M., Erlichman, C., Sloan, J. A., Furth, A., Safgren, S. L., Lathia, C. D. & Alberts, S. R., Oct 2005, In : Anti-Cancer Drugs. 16, 9, p. 997-1002 6 p.

Research output: Contribution to journalArticle

Matrix Metalloproteinase 12
Carboplatin
Etoposide
Pharmacokinetics
Matrix Metalloproteinase Inhibitors
63 Citations (Scopus)

A phase I and pharmacologic trial of two schedules of the proteasome inhibitor, PS-341 (Bortezomib, Velcade), in patients with advanced cancer

Dy, G. K., Thomas, J. P., Wilding, G., Bruzek, L., Mandrekar, S. J., Erlichman, C., Alberti, D., Binger, K., Pitot, H. C., Alberts, S. R., Hanson, L. J., Marnocha, R., Tutsch, K., Kaufmann, S. H. & Adjei, A., May 1 2005, In : Clinical Cancer Research. 11, 9, p. 3410-3416 7 p.

Research output: Contribution to journalArticle

Proteasome Inhibitors
Appointments and Schedules
Proteasome Endopeptidase Complex
Neoplasms
Fatigue